USPTO serial 99639439
FINLIPRO LIPOSOMAL FINASTERIDE
Status 641Office Action
- Filing date
- Feb 6, 2026
- Status date
- Jun 10, 2026
- Registration date
- —
- Examiner
- KRAVTSOFF, ELENA V N
Need help with FINLIPRO LIPOSOMAL FINASTERIDE?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: September 10, 2026
Office Action issues
The USPTO examiner requires an updated specimen that matches your trademark drawing and a formal disclaimer for the descriptive wording in your mark.
Owner
Omer Ugur
Yardley, PA, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicated balms for treatment of hair; Medicated serums for treatment of hair; Ampoules sold filled with therapeutic serums for treatment of hair | ACTIVE | Apr 24, 2023 |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jun 10, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 10, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Jun 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jun 5, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jun 4, 2026 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jun 4, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 6, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Feb 6, 2026 | NWAP | NEW APPLICATION ENTERED |